Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -207,174 | -92,528 | -381,387 | -151,993 | -23,387 |
| Depreciation Amortization | 9,702 | 3,606 | 5,867 | 2,230 | 1,161 |
| Accounts receivable | 7,214 | -7,625 | 26,129 | 67,580 | 39,608 |
| Accounts payable and accrued liabilities | 18,583 | -3,095 | -15,360 | -29,116 | -20,309 |
| Other Working Capital | -118,917 | -730,124 | -51,215 | -75,071 | -69,658 |
| Other Operating Activity | 63,304 | 36,947 | 147,383 | 55,496 | 73,148 |
| Operating Cash Flow | $-227,288 | $-792,819 | $-268,583 | $-130,874 | $563 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 601,800 | 560,069 | -220,692 | 176,156 | 77,888 |
| PPE Investments | -37,843 | -21,763 | -51,444 | -30,152 | -24,882 |
| Purchase Sale Intangibles | -3,640 | -1,486 | -5,640 | -4,275 | -2,615 |
| Other Investing Activity | -3,640 | -1,486 | -5,640 | -4,275 | -2,615 |
| Investing Cash Flow | $560,317 | $536,820 | $-277,776 | $141,729 | $50,391 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 770,000 | N/A | N/A |
| Debt Repayment | -432,596 | -44 | -286,764 | -123 | -82 |
| Common Stock Issued | 77,560 | 57,302 | 192,604 | 84,787 | 3,528 |
| Financing Cash Flow | $-355,036 | $57,258 | $675,840 | $84,664 | $3,446 |
| Exchange Rate Effect | -188 | -138 | 702 | 745 | 827 |
| Beginning Cash Position | 372,260 | 372,260 | 242,077 | 242,077 | 242,077 |
| End Cash Position | 350,065 | 173,381 | 372,260 | 338,341 | 297,304 |
| Net Cash Flow | $-22,195 | $-198,879 | $130,183 | $96,264 | $55,227 |
| Free Cash Flow | |||||
| Operating Cash Flow | -227,288 | -792,819 | -268,583 | -130,874 | 563 |
| Capital Expenditure | -37,843 | -21,763 | -51,444 | -30,152 | -24,882 |
| Free Cash Flow | -265,131 | -814,582 | -320,027 | -161,026 | -24,319 |